Dr. Noemi Lois is a clinical professor at Queen’s University Belfast and a consultant ophthalmologist and vitreoretinal surgeon at the Belfast Health and Social Care Trust in Northern Ireland.
Dr. Lois has been leading a program of research on diabetic retinopathy and its complications for the past 10 years, and she returns here as a guest author to discuss the implications of the recent DIAMONDS clinical trial.
The Diabetic Macular Oedema and Diode Subthreshold Micropulse Laser (DIAMONDS) clinical trial, which I presented in my previous post, found subthreshold MicroPulse laser therapy